{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T06:41:39Z","timestamp":1764398499369,"version":"3.46.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of the Republic of Korea","doi-asserted-by":"crossref","award":["RS-2023-00248980"],"award-info":[{"award-number":["RS-2023-00248980"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00700-6","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T15:35:47Z","timestamp":1762788947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structure-based identification and experimental evaluation of Oroxin A as a FYN kinase inhibitor"],"prefix":"10.1007","volume":"39","author":[{"given":"Vipul","family":"Agarwal","sequence":"first","affiliation":[]},{"given":"Chaitany Jayprakash","family":"Raorane","sequence":"additional","affiliation":[]},{"given":"Anugya","family":"Gupta","sequence":"additional","affiliation":[]},{"given":"Divya","family":"Shastri","sequence":"additional","affiliation":[]},{"given":"Vinit","family":"Raj","sequence":"additional","affiliation":[]},{"given":"Sangkil","family":"Lee","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"700_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417600","author":"S Silnitsky","year":"2023","unstructured":"Silnitsky S, Rubin SJS, Zerihun M, Qvit N (2023) An update on protein kinases as therapeutic targets-Part I: protein kinase C activation and its role in cancer and cardiovascular diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242417600","journal-title":"Int J Mol Sci"},{"key":"700_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-024-10819-7","author":"D Gopal","year":"2024","unstructured":"Gopal D, Muthuraj R, Balaya RDA et al (2024) Computational discovery of novel FYN kinase inhibitors: a cheminformatics and machine learning-driven approach to targeted cancer and neurodegenerative therapy. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-024-10819-7","journal-title":"Mol Divers"},{"key":"700_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124444","author":"C Matrone","year":"2020","unstructured":"Matrone C, Petrillo F, Nasso R, Ferretti G (2020) Fyn tyrosine kinase as harmonizing factor in neuronal functions and dysfunctions. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21124444","journal-title":"Int J Mol Sci"},{"key":"700_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4062\/biomolther.2019.214","volume":"28","author":"MJ Uddin","year":"2020","unstructured":"Uddin MJ, Dorotea D, Pak ES, Ha H (2020) Fyn kinase: a potential therapeutic target in acute kidney injury. Biomol Ther 28:213\u2013221. https:\/\/doi.org\/10.4062\/biomolther.2019.214","journal-title":"Biomol Ther"},{"key":"700_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-023-03930-0","volume":"21","author":"SF Peng","year":"2023","unstructured":"Peng SF, Fu Y (2023) FYN: emerging biological roles and potential therapeutic targets in cancer. J Transl Med 21:1\u201317. https:\/\/doi.org\/10.1186\/s12967-023-03930-0","journal-title":"J Transl Med"},{"key":"700_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/alzrt238","volume":"6","author":"HB Nygaard","year":"2014","unstructured":"Nygaard HB, van Dyck CH, Strittmatter SM (2014) Fyn kinase inhibition as a novel therapy for Alzheimer\u2019s disease. Alzheimers Res Ther 6:8. https:\/\/doi.org\/10.1186\/alzrt238","journal-title":"Alzheimers Res Ther"},{"key":"700_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-021-02518-3","author":"B Guglietti","year":"2021","unstructured":"Guglietti B, Sivasankar S, Mustafa S et al (2021) Fyn kinase activity and its role in neurodegenerative disease pathology: a potential universal target? Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-021-02518-3","journal-title":"Mol Neurobiol"},{"key":"700_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10456-005-9021-x","volume":"8","author":"XQ Werdich","year":"2005","unstructured":"Werdich XQ, Penn JS (2005) Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events. Angiogenesis 8:315\u2013326. https:\/\/doi.org\/10.1007\/s10456-005-9021-x","journal-title":"Angiogenesis"},{"key":"700_CR9","doi-asserted-by":"publisher","DOI":"10.4137\/CIN.S8104","volume":"10","author":"JB Nikas","year":"2011","unstructured":"Nikas JB, Boylan KLM, Skubitz APN, Low WC (2011) Mathematical prognostic biomarker models for treatment response and survival in epithelial ovarian cancer. Cancer Inform 10:CIN.S8104. https:\/\/doi.org\/10.4137\/CIN.S8104","journal-title":"Cancer Inform"},{"key":"700_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biom10111546","author":"A Baier","year":"2020","unstructured":"Baier A, Szyszka R (2020) Compounds from natural sources as protein kinase inhibitors. Biomolecules. https:\/\/doi.org\/10.3390\/biom10111546","journal-title":"Biomolecules"},{"key":"700_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1432-1033.1995.317_c.x","volume":"234","author":"F Meggio","year":"1995","unstructured":"Meggio F, Deana AD, Ruzzene M et al (1995) Different susceptibility of protein kinases to staurosporine inhibition: kinetic studies and molecular bases for the resistance of protein kinase CK2. Eur J Biochem 234:317\u2013322. https:\/\/doi.org\/10.1111\/j.1432-1033.1995.317_c.x","journal-title":"Eur J Biochem"},{"key":"700_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1182\/bloodadvances.2017011080","volume":"2","author":"RM Stone","year":"2018","unstructured":"Stone RM, Manley PW, Larson RA, Capdeville R (2018) Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. Blood Adv 2:444\u2013453. https:\/\/doi.org\/10.1182\/bloodadvances.2017011080","journal-title":"Blood Adv"},{"key":"700_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084565","author":"R Ramos","year":"2024","unstructured":"Ramos R, Vale N (2024) Dual drug repurposing: the example of Saracatinib. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25084565","journal-title":"Int J Mol Sci"},{"key":"700_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.molonc.2009.01.002","volume":"3","author":"TP Green","year":"2009","unstructured":"Green TP, Fennell M, Whittaker R et al (2009) Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530. Mol Oncol 3:248\u2013261. https:\/\/doi.org\/10.1016\/j.molonc.2009.01.002","journal-title":"Mol Oncol"},{"key":"700_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM et al (2021) Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 20:200\u2013216. https:\/\/doi.org\/10.1038\/s41573-020-00114-z","journal-title":"Nat Rev Drug Discov"},{"key":"700_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061578","author":"NE Thomford","year":"2018","unstructured":"Thomford NE, Senthebane DA, Rowe A et al (2018) Natural products for drug discovery in the 21st century: innovations for novel drug discovery. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19061578","journal-title":"Int J Mol Sci"},{"key":"700_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-023-05570-z","author":"A Ali","year":"2023","unstructured":"Ali A, Mir GJ, Ayaz A et al (2023) In silico analysis and molecular docking studies of natural compounds of Withania somnifera against bovine NLRP9. J Mol Model. https:\/\/doi.org\/10.1007\/s00894-023-05570-z","journal-title":"J Mol Model"},{"key":"700_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24071445","author":"W Wang","year":"2019","unstructured":"Wang W, Xiong X, Li X et al (2019) In silico investigation of the anti-tumor mechanisms of Epigallocatechin-3-gallate. Molecules. https:\/\/doi.org\/10.3390\/molecules24071445","journal-title":"Molecules"},{"key":"700_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.imed.2022.03.002","volume":"2","author":"F Yin","year":"2022","unstructured":"Yin F, Zhang X, Li Y et al (2022) In-silico analysis reveals the core targets and mechanisms of CA028, a new derivative of calycosin, in the treatment of colorectal cancer. Intell Med 2:127\u2013133. https:\/\/doi.org\/10.1016\/j.imed.2022.03.002","journal-title":"Intell Med"},{"issue":"D1","key":"700_CR20","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC et al (2021) The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 49(D1):D605\u2013D612. https:\/\/doi.org\/10.1093\/nar\/gkaa1074","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"700_CR21","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D et al (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607\u2013D613. https:\/\/doi.org\/10.1093\/nar\/gky1131","journal-title":"Nucleic Acids Res"},{"key":"700_CR22","doi-asserted-by":"publisher","first-page":"17217","DOI":"10.1038\/s41598-020-74251-1","volume":"10","author":"NS Sakle","year":"2020","unstructured":"Sakle NS, More SA, Mokale SN (2020) A network pharmacology-based approach to explore potential targets of Caesalpinia pulcherima: an updated prototype in drug discovery. Sci Rep 10:17217. https:\/\/doi.org\/10.1038\/s41598-020-74251-1","journal-title":"Sci Rep"},{"key":"700_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27144391","author":"NA Alturki","year":"2022","unstructured":"Alturki NA, Mashraqi MM, Alzamami A et al (2022) In-silico screening and molecular dynamics simulation of drug bank experimental compounds against SARS-CoV-2. Molecules. https:\/\/doi.org\/10.3390\/molecules27144391","journal-title":"Molecules"},{"key":"700_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2024.2308072","author":"V Agarwal","year":"2024","unstructured":"Agarwal V, Haldhar R, Hirad AH et al (2024) Repurposing FDA-approved drugs as NLRP3 inhibitors against inflammatory diseases: machine learning and molecular simulation approaches. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2024.2308072","journal-title":"J Biomol Struct Dyn"},{"key":"700_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-28716-8","volume":"13","author":"D Pirolli","year":"2023","unstructured":"Pirolli D, Righino B, Camponeschi C et al (2023) Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein\/ACE2 interface. Sci Rep 13:1\u201315. https:\/\/doi.org\/10.1038\/s41598-023-28716-8","journal-title":"Sci Rep"},{"key":"700_CR26","doi-asserted-by":"publisher","DOI":"10.33263\/BRIAC142.047","author":"V Agarwal","year":"2024","unstructured":"Agarwal V, Rehman M, Chaudhary R et al (2024) Exploring the potential of natural-like compounds as TNF\u03b1 inhibitors: an in-silico approach. Biointerface Res Appl Chem. https:\/\/doi.org\/10.33263\/BRIAC142.047","journal-title":"Biointerface Res Appl Chem"},{"key":"700_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-50992-7","volume":"14","author":"V Pandya","year":"2024","unstructured":"Pandya V, Rao P, Prajapati J et al (2024) Pinpointing top inhibitors for GSK3\u03b2 from pool of indirubin derivatives using rigorous computational workflow and their validation using molecular dynamics (MD) simulations. Sci Rep 14:1\u201325. https:\/\/doi.org\/10.1038\/s41598-023-50992-7","journal-title":"Sci Rep"},{"key":"700_CR28","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s11224-022-01999-9","volume":"33","author":"AO Mohammed","year":"2022","unstructured":"Mohammed AO, Abo-Idrees MI, Makki AA et al (2022) Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics. Struct Chem 33:1553\u20131567. https:\/\/doi.org\/10.1007\/s11224-022-01999-9","journal-title":"Struct Chem"},{"key":"700_CR29","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"700_CR30","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"700_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03724","volume":"6","author":"Y Isyaku","year":"2020","unstructured":"Isyaku Y, Uzairu A, Uba S (2020) Computational studies of a series of 2-substituted phenyl-2-oxo-, 2-hydroxyl- and 2-acylloxyethylsulfonamides as potent anti-fungal agents. Heliyon 6:e03724. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03724","journal-title":"Heliyon"},{"key":"700_CR32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4062\/biomolther.2023.156","volume":"32","author":"A Gupta","year":"2024","unstructured":"Gupta A, Haldhar R, Agarwal V et al (2024) Exploring the potential of natural products as FoxO1 inhibitors: an in silico approach. Biomol Ther (Seoul) 32:390\u2013398. https:\/\/doi.org\/10.4062\/biomolther.2023.156","journal-title":"Biomol Ther (Seoul)"},{"key":"700_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2023.103076","volume":"36","author":"S Khamouli","year":"2024","unstructured":"Khamouli S, Tabish Rehman M, Zegheb N et al (2024) Comprehensive in silico discovery of c-Src tyrosine kinase inhibitors in cancer treatment: a unified approach combining pharmacophore modeling, 3D QSAR, DFT, and molecular dynamics simulation. J King Saud Univ 36:103076. https:\/\/doi.org\/10.1016\/j.jksus.2023.103076","journal-title":"J King Saud Univ"},{"key":"700_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25092135","author":"BS Chhikara","year":"2020","unstructured":"Chhikara BS, Ashraf S, Mozaffari S et al (2020) Phenylpyrazalopyrimidines as tyrosine kinase inhibitors: synthesis, antiproliferative activity, and molecular simulations. Molecules. https:\/\/doi.org\/10.3390\/molecules25092135","journal-title":"Molecules"},{"key":"700_CR35","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jnutbio.2015.05.004","volume":"26","author":"B Wright","year":"2015","unstructured":"Wright B, Watson KA, McGuffin LJ et al (2015) GRID and docking analyses reveal a molecular basis for flavonoid inhibition of Src family kinase activity. J Nutr Biochem 26:1156\u20131165. https:\/\/doi.org\/10.1016\/j.jnutbio.2015.05.004","journal-title":"J Nutr Biochem"},{"key":"700_CR36","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1182\/blood.2021011405","volume":"138","author":"G Yang","year":"2021","unstructured":"Yang G, Wang J, Tan L et al (2021) The HCK\/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance. Blood 138:1966\u20131979. https:\/\/doi.org\/10.1182\/blood.2021011405","journal-title":"Blood"},{"key":"700_CR37","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1080\/14756366.2018.1469017","volume":"33","author":"G Poli","year":"2018","unstructured":"Poli G, Lapillo M, Granchi C et al (2018) Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors. J Enzyme Inhib Med Chem 33:956\u2013961. https:\/\/doi.org\/10.1080\/14756366.2018.1469017","journal-title":"J Enzyme Inhib Med Chem"},{"key":"700_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.6026\/97320630015419","volume":"15","author":"D Nedunchezhian","year":"2019","unstructured":"Nedunchezhian D, Langeswaran K, Santhoshkumar S (2019) Identification of novel inhibitor targeting Fyn kinase using molecular docking analysis. Bioinformation 15:419\u2013424. https:\/\/doi.org\/10.6026\/97320630015419","journal-title":"Bioinformation"},{"key":"700_CR39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1995-7645(12)60132-1","volume":"5","author":"W Jie","year":"2012","unstructured":"Jie W, He Q-Y, Luo B-T et al (2012) Inhibition of Pim-1 attenuates the proliferation and migration in nasopharyngeal carcinoma cells. Asian Pac J Trop Med 5:645\u2013650. https:\/\/doi.org\/10.1016\/S1995-7645(12)60132-1","journal-title":"Asian Pac J Trop Med"},{"key":"700_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4104595","volume":"2016","author":"KY Lam","year":"2016","unstructured":"Lam KY, Ling APK, Koh RY et al (2016) A review on medicinal properties of Orientin. Adv Pharmacol Sci 2016:4104595. https:\/\/doi.org\/10.1155\/2016\/4104595","journal-title":"Adv Pharmacol Sci"},{"key":"700_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7478","author":"Q Wang","year":"2022","unstructured":"Wang Q, Wei H, Zhou S et al (2022) Hyperoside: a review on its sources, biological activities, and molecular mechanisms. Phytother Res. https:\/\/doi.org\/10.1002\/ptr.7478","journal-title":"Phytother Res"},{"key":"700_CR42","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3390\/molecules27093009","volume":"27","author":"S Xu","year":"2022","unstructured":"Xu S, Chen S, Xia W et al (2022) Hyperoside: a review of its structure, synthesis, pharmacology, pharmacokinetics and toxicity. Molecules 27:3009","journal-title":"Molecules"},{"key":"700_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28093964","author":"S Zhong","year":"2023","unstructured":"Zhong S, Ye J, Deng Y et al (2023) Quercetagitrin inhibits tau accumulation and reverses neuroinflammation and cognitive deficits in P301S-tau transgenic mice. Molecules. https:\/\/doi.org\/10.3390\/molecules28093964","journal-title":"Molecules"},{"key":"700_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.phymed.2017.10.003","volume":"38","author":"W Sun","year":"2018","unstructured":"Sun W, Zhang B, Yu X et al (2018) Oroxin A from Oroxylum indicum prevents the progression from prediabetes to diabetes in streptozotocin and high-fat diet induced mice. Phytomedicine 38:24\u201334. https:\/\/doi.org\/10.1016\/j.phymed.2017.10.003","journal-title":"Phytomedicine"},{"key":"700_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.toxrep.2022.12.007","volume":"10","author":"SS Ahmed","year":"2023","unstructured":"Ahmed SS, Rahman MO, Alqahtani AS et al (2023) Anticancer potential of phytochemicals from Oroxylum indicum targeting Lactate Dehydrogenase A through bioinformatic approach. Toxicol Rep 10:56\u201375. https:\/\/doi.org\/10.1016\/j.toxrep.2022.12.007","journal-title":"Toxicol Rep"},{"key":"700_CR46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s00011-007-7005-6","volume":"56","author":"AP Rogerio","year":"2007","unstructured":"Rogerio AP, Kanashiro A, Fontanari C et al (2007) Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm Res 56:402\u2013408. https:\/\/doi.org\/10.1007\/s00011-007-7005-6","journal-title":"Inflamm Res"},{"key":"700_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910749","author":"A Nile","year":"2021","unstructured":"Nile A, Nile SH, Shin J et al (2021) Quercetin-3-glucoside extracted from apple pomace induces cell cycle arrest and apoptosis by increasing intracellular ROS levels. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms221910749","journal-title":"Int J Mol Sci"},{"key":"700_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5306\/wjco.v7.i2.189","volume":"7","author":"GdiC Orfali","year":"2016","unstructured":"Orfali GdiC, Duarte AC, Bonadio V et al (2016) Review of anticancer mechanisms of isoquercitin. World J Clin Oncol 7:189\u2013199. https:\/\/doi.org\/10.5306\/wjco.v7.i2.189","journal-title":"World J Clin Oncol"},{"key":"700_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep12273","volume":"5","author":"HY Fan","year":"2015","unstructured":"Fan HY, Yang MY, Qi D et al (2015) Salvianolic acid a as a multifunctional agent ameliorates doxorubicin-induced nephropathy in rats. Sci Rep 5:1\u201311. https:\/\/doi.org\/10.1038\/srep12273","journal-title":"Sci Rep"},{"key":"700_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212125","author":"J Ji","year":"2021","unstructured":"Ji J, Wang Z, Sun W et al (2021) Effects of cynaroside on cell proliferation, apoptosis, migration and invasion though the MET\/AKT\/mTOR axis in gastric cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222212125","journal-title":"Int J Mol Sci"},{"key":"700_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-024-01236-0","author":"SS Bhat","year":"2024","unstructured":"Bhat SS, Kulkarni SR, Uttarkar A, Niranjan V (2024) Computational insights into Papaveroline as an in silico drug candidate for Alzheimer\u2019s disease via Fyn tyrosine kinase inhibition. Mol Biotechnol. https:\/\/doi.org\/10.1007\/s12033-024-01236-0","journal-title":"Mol Biotechnol"},{"key":"700_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114054","volume":"229","author":"S Demuro","year":"2022","unstructured":"Demuro S, Sauvey C, Tripathi SK et al (2022) ARN25068, a versatile starting point towards triple GSK-3\u03b2\/FYN\/DYRK1A inhibitors to tackle tau-related neurological disorders. Eur J Med Chem 229:114054. https:\/\/doi.org\/10.1016\/j.ejmech.2021.114054","journal-title":"Eur J Med Chem"},{"key":"700_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/npre.2011.6108.1","author":"M Mannekumar","year":"2011","unstructured":"Mannekumar M, Sravana Lakshmi P, Vani Priyadarshini I et al (2011) Virtual screening to design drug molecules for human proto oncogene Fyn kinase. Nat Preced. https:\/\/doi.org\/10.1038\/npre.2011.6108.1","journal-title":"Nat Preced"},{"key":"700_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197160","author":"H Jeong","year":"2020","unstructured":"Jeong H, Shin JY, Lee K et al (2020) Caffeoyl-prolyl-histidine amide inhibits Fyn and alleviates atopic dermatitis-like phenotypes via suppression of NF-\u03baB activation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21197160","journal-title":"Int J Mol Sci"},{"key":"700_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2023.105603","volume":"106","author":"Z Li","year":"2023","unstructured":"Li Z, Wang Q, Zhang Z et al (2023) Chrysin alleviated CUMS-induced depressive-like behaviors in mice via directly targeting Fyn. J Funct Foods 106:105603. https:\/\/doi.org\/10.1016\/j.jff.2023.105603","journal-title":"J Funct Foods"},{"key":"700_CR56","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","volume":"12","author":"D Sun","year":"2022","unstructured":"Sun D, Gao W, Hu H, Zhou S (2022) Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B 12:3049\u20133062. https:\/\/doi.org\/10.1016\/j.apsb.2022.02.002","journal-title":"Acta Pharm Sin B"},{"key":"700_CR57","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1080\/17460441.2020.1798926","volume":"15","author":"S Kar","year":"2020","unstructured":"Kar S, Leszczynski J (2020) Open access in silico tools to predict the ADMET profiling of drug candidates. Expert Opin Drug Discov 15:1473\u20131487. https:\/\/doi.org\/10.1080\/17460441.2020.1798926","journal-title":"Expert Opin Drug Discov"},{"key":"700_CR58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.7324\/JAPS.2022.120418","volume":"12","author":"KMA Azzam","year":"2022","unstructured":"Azzam KMA, Negim ES, Aboul-Enein HY (2022) ADME studies of TUG-770 (a GPR-40 inhibitor agonist) for the treatment of type 2 diabetes using SwissADME predictor: in silico study. J Appl Pharm Sci 12:159\u2013169. https:\/\/doi.org\/10.7324\/JAPS.2022.120418","journal-title":"J Appl Pharm Sci"},{"key":"700_CR59","doi-asserted-by":"publisher","first-page":"6617","DOI":"10.1080\/07391102.2020.1796812","volume":"39","author":"R Yadav","year":"2021","unstructured":"Yadav R, Imran M, Dhamija P et al (2021) Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2. J Biomol Struct Dyn 39:6617\u20136632. https:\/\/doi.org\/10.1080\/07391102.2020.1796812","journal-title":"J Biomol Struct Dyn"},{"key":"700_CR60","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.2174\/092986712801323180","volume":"19","author":"S Kumar","year":"2012","unstructured":"Kumar S, Sharma R, Roychowdhury A (2012) Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: a medicinal chemistry perspective. Curr Med Chem 19:3605\u20133621. https:\/\/doi.org\/10.2174\/092986712801323180","journal-title":"Curr Med Chem"},{"key":"700_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275765","volume":"18","author":"S Basnet","year":"2023","unstructured":"Basnet S, Ghimire MP, Lamichhane TR et al (2023) Identification of potential human pancreatic \u03b1-amylase inhibitors from natural products by molecular docking, MM\/GBSA calculations, MD simulations, and ADMET analysis. PLoS ONE 18:e0275765. https:\/\/doi.org\/10.1371\/journal.pone.0275765","journal-title":"PLoS ONE"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00700-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T06:38:26Z","timestamp":1764398306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00700-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["700"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00700-6","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"There is no ethical approval required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human or animal rights"}}],"article-number":"120"}}